Add comment on:

IV Vitamin C Fights Cancer, Yet is Ignored by Pharma Status Quo
Fear of Profit Loss?
Intravenous Vitamin C is shown to fight cancer cells without harming healthy cells, yet the status quo of mainstream medicine continue to ridicule and ignore this potential lifesaving treatment. Is the fear of the pharma cartel that the vitamin is not able to be patented, thus reducing their potential for profit?

Guidelines for commenting on news articles:

Thanks for contributing to Indybay's open publishing newswire. You may use any format for your response article, from traditional academic discourse to subjective personal account. Please keep it on topic and concise. And please read our editorial policy, privacy, and legal statements before continuing. Or go back to the article.

Comment Title (required)
Author (required)
TEXT/HTML (required)

For plain text, URLs will be converted to clickable links. You may also use <a href="url">link</a> in plain text articles (other tags will be ignored unless you select "HTML"). When selecting "HTML", you must provide <p></p> and <br /> tags for paragraphs and line breaks.

Number Of Uploads
Maximum size of each uploaded file 480MB; maximum total size of all uploaded files 560MB; 6 hours maximum uploading time.
Accepted File Types: 3G2, 3GP, AMR, AVI, F4V, FLV, GIF, JPG, M3U, M4A, M4V, MOV, MP3, MP4, MPG, OGA, OGG, OGV, PDF, PLS, PNG, RAM, RM, TORRENT, WAV, WMA, WMV
For playability of media files on mobile devices, upload videos as MP4s with H.264 encoding. For audio, upload MP3s.
Anti-spam questions (Required) What is 6 plus 5?

You must preview your post before publishing.